Piramal Pharma Right Issue 2023

Piramal Pharma right issue
Rate this post

Piramal Pharma Limited is a leading pharmaceutical company that was incorporated in 2020 as a flagship company of Piramal Group. The company provides pharmaceutical products and services through its domestic and global distribution network. Piramal Pharma has a strong global presence with its 15 manufacturing facilities and a distribution network covering more than 100 countries. 

Piramal Pharma includes three major businesses. The first one is Piramal Pharma Solutions (PPS), which is an integrated Contract Development and Manufacturing Organization (CDMO) that offers development and manufacturing solutions to innovators and generic companies across the drug life cycle. The second business is Piramal Critical Care (PCC), which is a Complex Hospital Generics business providing a wide range of products such as inhalation anesthetics, injectable anti-infectives, intrathecal therapies for spasticity and pain management, and other therapies. The third business is the India Consumer Healthcare (ICH) business, which deals with over-the-counter products. 

Piramal Pharma Rights Issue Detail 

Issue Open  
Security Name Piramal Pharma Limited 
Issue Size (Shares) 
Issue Size (Amount) ₹1,050.00 Crores 
Issue Price  
Face Value ₹10 per share 
Listing At BSE, NSE 
Terms of Payment  

Company Financials  

Period Ended Total Assets Total Revenue Profit After Tax Net Worth Total Borrowing 
31-Mar-21 7,251.08 6,479.01 835.03 5,076.75 2,910.19 
31-Mar-22 8,729.82 6,834.90 375.96 6,069.94 4,023.28 
Amount in ₹ Crore 

Objects of the Issue: 

The company intends to utilize the net proceeds from the issue towards the funding of the following objects: 
1. Repayment or prepayment, in full or in part, of certain borrowings. 
2. General corporate purposes. 

Piramal Pharma Rights Issue Documents

Company Contact Information

Piramal Pharma Limited
Ground Floor, Piramal Ananta,
Agastya Corporate Park, Kamani Junction,
LBS Marg, Kurla, Mumbai 400 070

Phone: +91 22 3802 3000
Email: shareholders.ppl@piramal.com

Piramal Pharma Rights Issue Registrar

  1. Link Intime India Private Ltd
    Phone: +91-22-4918 6270
    Email: ppl.rights@linkintime.co.in

Piramal Pharma Rights Issue Lead Manager(s)

  1. ICICI Securities Limited


Please enter your comment!
Please enter your name here